Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Advances in Hematopoietic Stem Cell Transplantation in the Asia-Pacific Region: The Second Report From Apbmt 2005–2015
Sahar Tavakol Shiraji
Sahar Tavakol Shiraji

Assistant Professor of Hematology & Oncology

Department Internal Medicine

School of Medicine

Shariati Hospital

Hematologic Malignancies Research Center

Tehran University of Medical Sciences

All Documents
1. Age-Related Considerations in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia: A 10-Year Retrospective Study, International Journal of Hematology-Oncology and Stem Cell Research (2025)
2. Hypertension in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
3. Multiple Myeloma, Comprehensive Hematology and Stem Cell Research: Volume 1-5 (2024)
4. Comparable Outcomes of Pre- Versus Post-Tyrosine Kinase Inhibitor Era Treatment in Chronic Myeloid Leukemia: A Retrospective Cohort Study With Long-Term Follow-Up, Cell Transplantation (2023)
5. Modified Combination of Anti-Thymocyte Globulin (Atg) and Post-Transplant Cyclophosphamide (Ptcy) As Compared With Standard Atg Protocol in Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Leukemia, Frontiers in Immunology (2022)
6. Outcomes of Haploidentical Peripheral Stem Cell Transplantation With Combination of Post-Transplant Cyclophosphamide (Ptcy) and Anti-Thymocyte Globulin (Atg) Compared to Unrelated Donor Transplantation in Acute Myeloid Leukemia: A Retrospective 10-Year Experience, Leukemia Research (2022)
7. Selection of Suitable Alternative Donor in the Absence of Matched Sibling Donor: A Retrospective Single-Center Study to Compare Between Haploidentical, 10/10 and 9/10 Unrelated Donor Transplantation, International Journal of Hematology-Oncology and Stem Cell Research (2021)
8. Assessing the Prognostic Factors, Survival, and Recurrence Incidence of Triple Negative Breast Cancer Patients, a Single Center Study in Iran, PLoS ONE (2019)
9. Anti-Angiogenic Efficacy of Aflibercept and Bevacizumab in Primary Oral Squamous Cell Carcinoma Cells, Journal of Oral Pathology and Medicine (2018)